MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

MedAssets Company Profile (NASDAQ:MDAS)

Consensus Ratings for MedAssets (NASDAQ:MDAS) (?)
Ratings Breakdown: 13 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.07)
Consensus Price Target: $25.11 (19.91% downside)

Analysts' Ratings History for MedAssets (NASDAQ:MDAS)
Show:
DateFirmActionRatingPrice TargetActions
1/27/2016William BlairReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/25/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2015Leerink SwannReiterated RatingHold$22.00 -> $31.35View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015JPMorgan Chase & Co.Initiated CoverageNeutral$19.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015SunTrustDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Wells FargoDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Jefferies GroupDowngradeBuy -> Hold$25.00 -> $31.35View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015FBR & Co.Boost Price TargetMarket Perform$20.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Piper JaffrayUpgradeUnderweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Avondale PartnersInitiated CoverageOutperform$27.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2015Deutsche BankReiterated RatingHold$22.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2015Topeka Capital MarketsLower Price TargetHold$23.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/3/2015RBC CapitalBoost Price TargetSector Perform$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015Evercore ISIDowngradeBuy -> Hold$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015StephensReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2015Citigroup Inc.Reiterated RatingHold$21.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Bank of AmericaDowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/16/2015Robert W. BairdDowngradeOutperform -> Neutral$30.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Raymond JamesDowngradeOutperform -> Market Perform$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for MedAssets (NASDAQ:MDAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
2/15/2016        
11/2/2015Q315$0.28$0.32$187.34 million$117.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q2$0.27$0.31$187.45 million$190.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115$0.30$0.31$184.33 million$185.58 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q414$0.39$0.39$195.00 million$198.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314$0.31$0.34$172.50 million$175.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q214$0.29$0.30$175.70 million$175.42 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114$0.33$0.32$172.37 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q413$0.28$0.30$165.64 million$170.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313$0.30$0.31$166.78 million$166.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.26$0.30$167.64 million$170.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013$0.30$0.41$164.75 million$172.84 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2013Q4 2012$0.28$0.27$159.84 million$163.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2012$0.26$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012$0.22$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.18$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012$0.32$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011$0.16$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2011$0.16$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.16$0.17ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$0.22$0.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for MedAssets (NASDAQ:MDAS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for MedAssets (NASDAQ:MDAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for MedAssets (NASDAQ:MDAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/26/2015John A BardisDirectorSell2,000$19.73$39,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015John A BardisDirectorSell100,000$19.45$1,945,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015R Halsey WiseCEOBuy110,300$18.15$2,001,945.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Keith L ThurgoodInsiderSell5,681$19.54$111,006.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Harris Iv HymanDirectorSell3,334$20.50$68,347.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014John A BardisCEOSell100,000$20.02$2,002,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014John A BardisCEOSell191,833$20.74$3,978,616.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014John A BardisCEOSell208,167$21.48$4,471,427.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Jonathan H GlennInsiderSell7,300$22.62$165,126.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Jonathan H GlennInsiderSell500$22.50$11,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Charles O GarnerCFOSell3,167$22.81$72,239.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2014Terrence J MulliganDirectorSell1,000$23.30$23,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Terrence MulliganDirectorSell1,000$22.93$22,930.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014R Halsey WiseDirectorBuy8,950$22.31$199,674.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2014Terrence MulliganDirectorSell1,000$24.56$24,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2014Terrence MulliganDirectorSell1,000$25.24$25,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Charles GarnerCFOSell8,949$24.05$215,223.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Charles GarnerCFOSell15,207$20.83$316,761.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Terrence MulliganDirectorSell2,000$21.97$43,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013John RutherfordDirectorSell13,000$21.41$278,330.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2013Bruce WessonDirectorSell60,263$20.54$1,237,802.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/8/2013John BardisCEOSell200,000$22.04$4,408,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2013Lance M CulbrethCAOSell2,000$26.45$52,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2013Terrence MulliganDirectorSell1,000$24.64$24,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2013Terrence MulliganDirectorSell1,000$24.21$24,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Lance M CulbrethCAOSell4,000$24.23$96,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013Jonathan H GlennInsiderSell12,268$24.00$294,432.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013Charles GarnerCFOSell2,017$23.02$46,431.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013Harris Iv HymanDirectorSell3,199$23.26$74,408.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Harris Iv HymanDirectorSell5,985$23.50$140,647.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2013C PiccoloDirectorSell17,487$22.94$401,151.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2013John BardisCEOSell17,304$23.04$398,684.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013John BardisCEOSell10,000$22.87$228,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Terrence MulliganDirectorSell5,000$23.50$117,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013John RutherfordDirectorSell50,000$23.62$1,181,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Lance M CulbrethCAOSell22,866$23.34$533,692.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Gregory StrobelInsiderSell4,025$22.78$91,689.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Terrence MulliganDirectorSell29,446$23.39$688,741.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2013Michael Patrick NolteCOOSell20,000$21.04$420,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2013Lance M CulbrethCAOSell4,500$20.45$92,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2013Michael Patrick NolteCOOSell19,222$19.63$377,327.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2013Rand A BallardInsiderSell13,163$20.00$263,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2013Terrence J MulliganDirectorSell55,000$20.00$1,100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Lance M CulbrethCAOSell16,000$18.54$296,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2013Charles O GarnerCFOSell15,038$19.38$291,436.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012Gregory A StrobelInsiderSell10,000$16.24$162,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012John A BardisCEOSell107,550$16.51$1,775,650.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012John A BardisCEOSell71,340$16.34$1,165,695.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for MedAssets (NASDAQ:MDAS)
DateHeadline
05/09/16 08:04 AMMedAssets, Inc. (NASDAQ:MDAS) Broker Price Targets For The Coming Week - Share Trading News - MedAssets, Inc. (NASDAQ:MDAS) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of MedAssets, Inc. (NASDAQ:MDAS). The latest reports which are currently in issue on Sunday 8th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/04/16 06:50 AMAverage Analyst Rating for MedAssets, Inc. (NASDAQ:MDAS) - B.O.D.Y Confidential - Average Analyst Rating for MedAssets, Inc. (NASDAQ:MDAS)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of N/A on MedAssets, Inc. (NASDAQ:MDAS) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
04/24/16 08:15 AMNext Weeks Broker Price Targets For MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News - Next Weeks Broker Price Targets For MedAssets, Inc. (NASDAQ:MDAS)Share Trading News11/03/2015 – MedAssets, Inc. was downgraded to “neutral” by analysts at SunTrust. 11/03/2015 – MedAssets, Inc. had its “market perform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 20 price target on the stock. 11/02/2015 ...and more »
04/23/16 08:39 AMNew Analyst Ratings On MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers - New Analyst Ratings On MedAssets, Inc. (NASDAQ:MDAS)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of MedAssets, Inc. (NASDAQ:MDAS). The latest broker reports which are currently outstanding on Friday 22nd of April state 0 analysts have a rating of “strong buy”, 0 analysts ...
04/22/16 09:20 AMMedAssets, Inc. (NASDAQ:MDAS) Share Rating Recap - The Post - MedAssets, Inc. (NASDAQ:MDAS) Share Rating RecapThe PostShares of MedAssets, Inc. (NASDAQ:MDAS) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/15/16 12:20 PMMedAssets, Inc. (NASDAQ:MDAS) Analyst Recommendation Outlook - Clinton Financial - MedAssets, Inc. (NASDAQ:MDAS) Analyst Recommendation OutlookClinton FinancialThere are N/A analysts providing ratings for MedAssets, Inc. (NASDAQ:MDAS). N/A have given the stock a “Strong Buy”, N/A rate it a “Buy”, N/A are rating the stock a Hold, and N/A are recommending “Sell”. Every recommendation can be mapped to an integer ...
04/14/16 01:40 PMMedAssets, Inc. (NASDAQ:MDAS) Latest Broker Coverage - Risers & Fallers - MedAssets, Inc. (NASDAQ:MDAS) Latest Broker CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of MedAssets, Inc. (NASDAQ:MDAS). According to the latest broker reports outstanding on Tuesday 12th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy ...
04/12/16 12:16 PMCurrent Price Targets For MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers - Current Price Targets For MedAssets, Inc. (NASDAQ:MDAS)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of MedAssets, Inc. (NASDAQ:MDAS). The latest broker reports which are currently outstanding on Monday 11th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
04/12/16 12:15 PMEarnings Watch on MedAssets, Inc. (NASDAQ:MDAS) - RiversideGazette.com - Earnings Watch on MedAssets, Inc. (NASDAQ:MDAS)RiversideGazette.comMedAssets, Inc. (NASDAQ:MDAS) has a consensus earnings per share estimate for the current quarter of $N/A based on compiled analyst projections. The company is next expected to release earnings on or around N/A for the period ending N/A. For the ...and more »
04/09/16 11:42 AMRecently Changed Price Targets On MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers - Recently Changed Price Targets On MedAssets, Inc. (NASDAQ:MDAS)Risers & Fallers06/18/2015 – MedAssets, Inc. had its “market perform” rating reiterated by analysts at Stephens. The share price of MedAssets, Inc. (NASDAQ:MDAS) was up +0.00% during the last trading session, with a day high of 0.00. 0 shares were traded on MedAssets, ...and more »
04/08/16 12:26 PMIs MedAssets, Inc. (NASDAQ:MDAS) a Consensus Buy? - Clinton Financial - Is MedAssets, Inc. (NASDAQ:MDAS) a Consensus Buy?Clinton FinancialEquity research firms covering public U.S companies have a workforce of analysts dedicating their time covering the most popular stocks. Their reports are delivered to institutional investors in order to help make investment decisions. The information ...and more »
04/07/16 12:46 PMAnalyst Ratings Check MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune - Analyst Ratings Check MedAssets, Inc. (NASDAQ:MDAS)Business Standard TribuneCovering sell-side analysts have an average rating of N/A on shares of MedAssets, Inc. (NASDAQ:MDAS). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating lands on a 1 to 5 scale. A 1 or 2 ...and more »
04/07/16 12:46 PMBroker Roundup For MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News - Broker Roundup For MedAssets, Inc. (NASDAQ:MDAS)Share Trading News06/18/2015 – MedAssets, Inc. had its “market perform” rating reiterated by analysts at Stephens. The share price of MedAssets, Inc. (NASDAQ:MDAS) was up +0.00% during the last trading session, with a day high of 0.00. 0 shares were traded on MedAssets, ...
04/05/16 01:49 PMMedAssets, Inc. (NASDAQ:MDAS) - Broker Update - Risers & Fallers - MicroCap MagazineMedAssets, Inc. (NASDAQ:MDAS) - Broker UpdateRisers & FallersBelow are the most recently updated broker updates which include ratings and price targets for MedAssets, Inc. (NASDAQ:MDAS). 11/20/2015 – Broker: Leerink Swann Rating: market perform New Target: 31.35 reiteration. 11/17/2015 – Broker: JP Morgan ...State Board of Administration of Florida Retirement System Has $1497000 Position in MedAssets, Inc. (MDAS)Financial Market Newsall 2 news articles »
04/05/16 01:49 PMLatest Analyst Ratings For MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News - Latest Analyst Ratings For MedAssets, Inc. (NASDAQ:MDAS)Share Trading News11/03/2015 – MedAssets, Inc. was downgraded to “neutral” by analysts at SunTrust. 11/03/2015 – MedAssets, Inc. had its “market perform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 20 price target on the stock. 11/02/2015 ...
04/05/16 01:49 PMEarnings View for MedAssets, Inc. (NASDAQ:MDAS) - RiversideGazette.com - Earnings View for MedAssets, Inc. (NASDAQ:MDAS)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $N/A on shares of MedAssets, Inc. (NASDAQ:MDAS). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released on or around N/A for the ...and more »
04/03/16 01:33 PMBroker Outlook For The Week Ahead MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News - Broker Outlook For The Week Ahead MedAssets, Inc. (NASDAQ:MDAS)Share Trading NewsMedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company ...
04/02/16 12:28 PMFreshford Capital Management Llc Increased Medassets Inc (NASDAQ:MDAS) by $40.95 Million as Shares Rose - Clinton Financial - Freshford Capital Management Llc Increased Medassets Inc (NASDAQ:MDAS) by $40.95 Million as Shares RoseClinton FinancialMichael Doheny increased its stake in Medassets Inc (NASDAQ:MDAS) by 3669.26% based on its latest Q4 2015 regulatory filing with the SEC. Freshford Capital Management Llc bought 1.36 million shares as the company's stock rose 48.96% with the ...Freshford Capital Management Llc Decreased Stake in Webmd Health Corp (NASDAQ:WBMD) by $39.79 Million as ...Franklin Independentall 2 news articles »
04/02/16 12:28 PMShould Investors Buy MedAssets, Inc. (NASDAQ:MDAS)? - Clinton Financial - Should Investors Buy MedAssets, Inc. (NASDAQ:MDAS)?Clinton FinancialOut of the N/A analysts covering shares of MedAssets, Inc. (NASDAQ:MDAS), N/A rate it a “Strong Buy”, N/A rate it a “Buy”, N/A are advising to Hold the shares and N/A are saying “Sell”. Each recommendation can be mapped to an integer using a 1 to 5 scale.and more »
03/30/16 01:37 PMEarnings Outlook on MedAssets, Inc. (NASDAQ:MDAS) - RiversideGazette.com - Earnings Outlook on MedAssets, Inc. (NASDAQ:MDAS)RiversideGazette.comAnalysts and investors will be looking forward to the next earnings release from MedAssets, Inc. (NASDAQ:MDAS) which is scheduled to be on or around N/A for the period ending N/A. Covering sell-side analysts have a current quarter earnings per share ...and more »
03/30/16 01:37 PMAverage Rating Watch MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune - Average Rating Watch MedAssets, Inc. (NASDAQ:MDAS)Business Standard TribuneStreet analysts that cover MedAssets, Inc. (NASDAQ:MDAS) presently have an average broker rating of N/A on the stock. This average rating comes from Zacks Research compiling polled analyst ratings taken into consideration. The average rating falls on a ...and more »
03/17/16 01:14 PMAverage Analyst Rating Update on MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune - Average Analyst Rating Update on MedAssets, Inc. (NASDAQ:MDAS)Business Standard TribuneWall Street analysts have an average broker recommendation of N/A on MedAssets, Inc. (NASDAQ:MDAS) shares. The rating is determined by taking the average of all analyst recommendations taken into consideration by Zacks Research.and more »
03/17/16 01:14 PMWhat Is The ABR Of MedAssets, Inc. (NASDAQ:MDAS)? - Investor Newswire - What Is The ABR Of MedAssets, Inc. (NASDAQ:MDAS)?Investor NewswireZacks Research has reported MedAssets, Inc. (NASDAQ:MDAS) to have ABR of N/A. Investors always look out to invest in the companies that are considered as best performing in the industry. A group of investors acknowledges the value of research reports ...and more »
03/17/16 01:14 PMCan MedAssets, Inc. (NASDAQ:MDAS) Top Street's Expectations? - Stocks Daily - Can MedAssets, Inc. (NASDAQ:MDAS) Top Street's Expectations?Stocks DailyThe research entity Zacks drafted a research report on MedAssets, Inc. (NASDAQ:MDAS) and as per it's the company's stock can touch $N/A in FY2017. Zacks polled N/A brokerage houses and after that determined price target of $N/A on the stock. As per the ...and more »
03/11/16 03:30 PMSmall-Caps: Hedge Fund Favorites -
03/10/16 12:54 PMEarnings Glance MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune - Earnings Glance MedAssets, Inc. (NASDAQ:MDAS)Business Standard TribuneAnalysts tracking shares of MedAssets, Inc. (NASDAQ:MDAS) are looking for $N/A per share on a consensus basis for the quarter. This estimate is based on analysts tracked by Zacks Research. This number may vary from other data sources that provide ...and more »
03/03/16 01:58 PMStock Rating & Analysis on MedAssets, Inc. (NASDAQ:MDAS) - WallStreet.org - Stock Rating & Analysis on MedAssets, Inc. (NASDAQ:MDAS)WallStreet.orgMedAssets, Inc. (NASDAQ:MDAS) company shares are recently being watched closely by Wall Street professionals and certain individuals that give personal stock ratings (crowd). Although company fundamentals are important when predicting future stock ...and more »
02/17/16 11:52 AMFreshford Capital Management Llc Increased Medassets Inc (NASDAQ:MDAS) by $40.95 Million as Shares Rose - Michael Doheny increased its stake in Medassets Inc (NASDAQ:MDAS) by 3669.26% based on its latest Q4 2015 regulatory filing with the SEC. Freshford Capital Management Llc bought 1.36M shares as the company’s stock rose 48.96% with the market. The hedge ...
02/16/16 11:47 AMUpdated Price Targets On MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers - Updated Price Targets On MedAssets, Inc. (NASDAQ:MDAS)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of MedAssets, Inc. (NASDAQ:MDAS). The latest broker reports which are currently outstanding on Tuesday 16th of February state 0 analysts have a rating of “strong buy”, ...and more »
02/10/16 11:26 AMJunk Bond Issuance Gained Traction: 5 Key Deals -
02/03/16 11:07 PMLeveraged Loan Funds Continued to Witness Outflows Last Week -
02/03/16 10:32 AMMedAssets, Inc. (NASDAQ:MDAS): Quarterly Earnings Update - Investor Newswire - MedAssets, Inc. (NASDAQ:MDAS): Quarterly Earnings UpdateInvestor NewswireAs per the research firms that were included in Zacks Research survey, MedAssets, Inc. (NASDAQ:MDAS) is projected an EPS of $N/A for last quarter. The firm can release the earnings report on or around N/A. Since the ratings compiled by Zacks Research ...and more »
01/30/16 08:07 PMLeveraged Loans Issuance Fell Last Week -
01/29/16 10:24 AMMedAssets, Inc. (NASDAQ:MDAS) Short Interest Update - Market Briefing - MedAssets, Inc. (NASDAQ:MDAS) Short Interest UpdateMarket BriefingMedAssets, Inc. (NASDAQ:MDAS), A increase of 197,559 shares or 17.8% was observed in the short interest of MedAssets, Inc. The interest on January 15,2016 came in at 1,308,349 shares and as per the average daily trading of 1,800,126 shares, the days ...
01/29/16 07:30 AMMedAssets Named Category Leader in “2015/2016 Best in KLAS” Report - [GlobeNewswire] - ATLANTA, Jan. 29, 2016-- MedAssets ranked #1 in claims management and revenue cycle outsourcing in the newly published“ 2015/ 2016 Best in KLAS” report, which is based on industry feedback. The report ...
01/28/16 12:34 PMVizient, Inc. -- Moody's assigns B2 CFR to Vizient, Inc.; stable outlook - [at Moody's] - Approximately $2 billion of newly rated debt. New York, January 28, 2016-- Moody's Investors Service today assigned a B2 Corporate Family Rating and B2-PD Probability of Default Rating to Vizient, Inc.. ...
01/27/16 05:12 PMNew Lifetime High Reached By MedAssets (MDAS) - See the FREE profile for MDAS NOW at Trade-Ideas More details on MDAS: MedAssets, Inc., a performance improvement company, provides technology-enabled products and services for hospitals, health systems, non-acute healthcare providers, payers, and other ...
01/27/16 02:22 PMMEDASSETS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Ag -
01/27/16 09:55 AMPamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion - GlobeNewswire (press release) - Pamplona Capital Management Completes Acquisition of MedAssets for $2.75 BillionGlobeNewswire (press release)ATLANTA, Jan. 27, 2016 (GLOBE NEWSWIRE) -- MedAssets, Inc. (NASDAQ:MDAS), a leading healthcare performance improvement company that serves four out of every five hospitals in the United States, announced that Pamplona Capital Management, ...and more »
01/27/16 09:55 AMAnalyst Coverage Updates - MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers - Analyst Coverage Updates - MedAssets, Inc. (NASDAQ:MDAS)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of MedAssets, Inc. (NASDAQ:MDAS). The latest broker reports which are currently outstanding on Wednesday 27th January state 0 analysts have a rating of “strong buy”, ...and more »
01/27/16 09:30 AMPamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion - [GlobeNewswire] - ATLANTA, Jan. 27, 2016-- MedAssets, Inc., a leading healthcare performance improvement company that serves four out of every five hospitals in the United States, announced that Pamplona Capital Management, ...
01/27/16 09:30 AMPamplona Capital Management Completes Acquisition of MedAssets -
01/22/16 04:56 PMMedAssets Inc. (MDAS) is Trading Higher on Unusual Volume for January 22 - Equities.com - MedAssets Inc. (MDAS) is Trading Higher on Unusual Volume for January 22Equities.comMedAssets Inc. (MDAS) experienced unusually high volume on Jan. 22, as the stock gained 0.14% to a closing price of $31.28. The stock saw 2.13 million shares trade hands over the course of the day on 5,305 trades. Given that the stock's average daily ...and more »
01/21/16 04:57 PMMedAssets, Inc. (NASDAQ:MDAS) - Stock Sentiment And ABR Update - Investor Newswire - MedAssets, Inc. (NASDAQ:MDAS) - Stock Sentiment And ABR UpdateInvestor NewswireZacks Research has given an average broker rating of 3.06 to MedAssets, Inc. (NASDAQ:MDAS)'s shares. Zacks assigns a simplified score in between one and five against the complex analysts' ratings. A score towards 1-2 typically means a consensus Buy, ...and more »
01/20/16 08:45 AMPamplona Capital Management Names CEO, Executive Leadership Team for Combined MedAssets-Precyse Enterprise - [at noodls] - Global business transformation leader will take the helm as CEO; New leadership team positions the soon-to-be-combined company as a market leader in end-to-end integrated revenue cycle solutions & --(BUSINESS ...
01/19/16 09:28 AMMedAssets Inc. (MDAS) is Trading Lower on Unusual Volume for January 18 - Equities.com - MedAssets Inc. (MDAS) is Trading Lower on Unusual Volume for January 18Equities.comMedAssets Inc. (MDAS) experienced unusually high volume on Jan. 18, as the stock lost 0.1% to a closing price of $31.16. The stock saw 1.52 million shares trade hands over the course of the day on 4,980 trades. Given that the stock's average daily ...and more »
01/15/16 01:50 PMMedAssets' Shareholders Approve Takeover by Pamplona -
01/14/16 03:13 PMMEDASSETS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statem -
01/14/16 01:26 PMMedAssets' Stockholders Approve Merger With Pamplona Capital Management - [at noodls] - , (GLOBE NEWSWIRE) -- (NASDAQ:MDAS) today announced that its stockholders approved the previously disclosed Agreement and Plan of Merger ('Merger Agreement') with at its special meeting of stockholders ...
01/06/16 02:30 PMMedAssets, Inc. (New). -- Moody's assigns B3 CFR to MedAssets, Inc. (New); rates LBO financing -
About MedAssets

MedAssets logoMedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company's technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company's solutions across decentralized health care organizations, providing standardization and compliance.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Exchange: NASDAQ
  • Symbol: MDAS
  • CUSIP: 58404510
Key Metrics:
  • Previous Close: $31.35
  • 50 Day Moving Average: $30.97
  • 200 Day Moving Average: $25.46
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Quarter EPS Consensus Estimate: $1.30 EPS
Additional Links:
MedAssets (NASDAQ:MDAS) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha